# Environmental occurrence of optrA-mediated linezolid resistance in Enterococcus isolates and genomic insights into Enterococcus faecium ST54 co-harboring optrA, poxtA, and cfr(D) genes

**Authors:** Lucas David Rodrigues Dos Santos, João Pedro Rueda Furlan, Rafael da Silva Rosa, Micaela Santana Ramos, Letícia Franco Gervasoni, Eduardo Angelino Savazzi, Teresa Nogueira, Eliana Guedes Stehling

PMC · DOI: 10.1007/s11274-026-04786-4 · 2026-01-31

## TL;DR

This study finds linezolid-resistant Enterococcus bacteria in Brazilian aquatic environments, highlighting the spread of antibiotic resistance genes in nature.

## Contribution

The study reports the first environmental occurrence of Enterococcus faecium ST54 co-harboring optrA, poxtA, and cfr(D) genes in South America.

## Key findings

- 181 Enterococcus isolates were obtained, with 37% carrying the optrA gene.
- One E. faecium isolate (EW1587) co-harbored optrA, poxtA, and cfr(D) genes and belonged to ST54.
- The resistance genes were plasmid-borne and remained stable in vitro for 30 days.

## Abstract

Linezolid-resistant Enterococcus species have emerged worldwide, with resistance mainly driven by plasmid-borne optrA, poxtA, and cfr genes. While the optrA gene has been increasingly identified in humans and animals, its presence in the environmental sector remains poorly studied, especially in South America. This study aimed to investigate and characterize linezolid resistance genes in isolates of Enterococcus faecium and Enterococcus faecalis obtained from aquatic ecosystems in 51 cities in the state of São Paulo, Brazil. Phenotypic, molecular, and genomic analyses were used for this proposal. Accordingly, 181 Enterococcus isolates were obtained, with 67 (37%) harboring the optrA gene. Most isolates exhibited multidrug resistance, and the minimum inhibitory concentration to linezolid ranged from 0.5 to > 64 mg/L. Several virulence genes and plasmid replicons were observed, with gelE and rep9 being most prevalent, respectively. Ten isolates co-harbored the optrA and poxtA genes and belonged to the known sequence type (ST) 1221 (E. faecium) and ST283, ST253, ST234, and ST1230 (E. faecalis), as well as to the new ST3018, ST3022, ST3026, and ST3027 (E. faecium), and ST2126 (E. faecalis). Moreover, one E. faecium isolate (EW1587) carried optrA, poxtA, and cfr(D) genes and, therefore, was submitted to genomic characterization. Isolate EW1587 belonged to ST54 and was closely related to an animal-derived Brazilian strain. In silico analysis predicted that optrA, poxtA, and cfr(D) genes were plasmid-borne, whereas in vitro stability tests demonstrated that these genes remained stable for 30 days. These results highlight the environmental spread of transferable oxazolidinone resistance genes, with E. faecium ST54 co-carrying optrA, poxtA, and cfr(D) genes. Therefore, continuous monitoring is essential to fully elucidate the mechanisms driving the spread and evolution of linezolid resistance across environmental reservoirs.

The online version contains supplementary material available at 10.1007/s11274-026-04786-4.

## Linked entities

- **Genes:** optrA (ABC-F type ribosomal protection protein OptrA) [NCBI Gene 67039167], cfr (Radical SAM superfamily protein) [NCBI Gene 3500881], gelE (gelatinase GelE) [NCBI Gene 60894106]
- **Chemicals:** linezolid (PubChem CID 3929)
- **Species:** Enterococcus faecium (taxon 1352), Enterococcus faecalis (taxon 1351), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** vanB [NCBI Gene 6779647], surface protein [NCBI Gene 6989545], vanA [NCBI Gene 13874695], Cfr [NCBI Gene 9742423], erm(B) [NCBI Gene 15414719]
- **Diseases:** urinary tract infections (MESH:D014552), LRE (MESH:D060467), infections (MESH:D007239), pneumonia (MESH:D011014), meningitis (MESH:D008580), bacteremia (MESH:D016470)
- **Chemicals:** tetracyclines (MESH:D013754), vancomycin (MESH:D014640), tedizolid (MESH:C546016), tetracycline (MESH:D013752), fosfomycin (MESH:D005578), Linezolid (MESH:D000069349), chloramphenicol (MESH:D002701), aminoglycoside (MESH:D000617), florfenicol (MESH:C035534), erythromycin (MESH:D004917), Brain Heart Infusion broth (-), macrolides (MESH:D018942), ciprofloxacin (MESH:D002939), minocycline (MESH:D008911), norfloxacin (MESH:D009643), oxazolidinone (MESH:D023303), fluoroquinolones (MESH:D024841), imipenem (MESH:D015378), ampicillin (MESH:D000667), levofloxacin (MESH:D064704), nitrofurantoin (MESH:D009582), water (MESH:D014867), oxytetracycline (MESH:D010118), agar (MESH:D000362), pleuromutilins (MESH:C004262), doxycycline (MESH:D004318), streptogramin A (MESH:D025364), glycerol (MESH:D005990), teicoplanin (MESH:D017334), rifampicin (MESH:D012293), streptomycin (MESH:D013307), lincosamides (MESH:D055231), gentamicin (MESH:D005839)
- **Species:** Streptococcus parasuis (species) [taxon 1501662], Staphylococcus aureus (species) [taxon 1280], Streptococcus suis (species) [taxon 1307], Enterococcus faecalis (species) [taxon 1351], Vagococcus lutrae (species) [taxon 81947], Enterococcus faecalis V583 (strain) [taxon 226185], Listeria monocytogenes (species) [taxon 1639], Clostridium perfringens (species) [taxon 1502], Enterococcus faecium (species) [taxon 1352], Staphylococcus sp. (species) [taxon 29387], Enterococcus gallinarum (species) [taxon 1353], Homo sapiens (human, species) [taxon 9606], Mycolicibacterium smegmatis (species) [taxon 1772], Enterococcus faecium DO (strain) [taxon 333849], Sus scrofa (pig, species) [taxon 9823], Streptomyces sp. t54 (species) [taxon 1828162], Enterococcus (genus) [taxon 1350], Enterococcus casseliflavus (species) [taxon 37734], Escherichia coli (E. coli, species) [taxon 562]
- **Mutations:** V24A, C2192A, Tyr176Asp, L177I, T2179C, N496K, A216S, G66E, T2131A, T2182C, K144Q, A2211G, A2189G, T172A, R34Q, G2576T, A2190C, A499T, E525D, E100Q, A2571G, A2154T, T324A, S27G, C2136T, G2153A, G2134A, A2210G, G2595C, M100, Gly393Asp

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12858486/full.md

---
Source: https://tomesphere.com/paper/PMC12858486